279 related articles for article (PubMed ID: 25768836)
1. Targeting the thyroid-stimulating hormone receptor with small molecule ligands and antibodies.
Davies TF; Latif R
Expert Opin Ther Targets; 2015 Jun; 19(6):835-47. PubMed ID: 25768836
[TBL] [Abstract][Full Text] [Related]
2. TSHR as a therapeutic target in Graves' disease.
Smith TJ
Expert Opin Ther Targets; 2017 Apr; 21(4):427-432. PubMed ID: 28127991
[TBL] [Abstract][Full Text] [Related]
3. Small molecule TSHR agonists and antagonists.
Neumann S; Gershengorn MC
Ann Endocrinol (Paris); 2011 Apr; 72(2):74-6. PubMed ID: 21511239
[TBL] [Abstract][Full Text] [Related]
4. The thyroid-stimulating hormone receptor: impact of thyroid-stimulating hormone and thyroid-stimulating hormone receptor antibodies on multimerization, cleavage, and signaling.
Latif R; Morshed SA; Zaidi M; Davies TF
Endocrinol Metab Clin North Am; 2009 Jun; 38(2):319-41, viii. PubMed ID: 19328414
[TBL] [Abstract][Full Text] [Related]
5. A human monoclonal autoantibody to the thyrotropin receptor with thyroid-stimulating blocking activity.
Sanders J; Evans M; Betterle C; Sanders P; Bhardwaja A; Young S; Roberts E; Wilmot J; Richards T; Kiddie A; Small K; Platt H; Summerhayes S; Harris R; Reeve M; Coco G; Zanchetta R; Chen S; Furmaniak J; Smith BR
Thyroid; 2008 Jul; 18(7):735-46. PubMed ID: 18631002
[TBL] [Abstract][Full Text] [Related]
6. Novel Antimurine Thyroid-Stimulating Hormone Receptor Monoclonal Antibodies.
Klee AN; Torchia JA; Freeman GJ
Monoclon Antib Immunodiagn Immunother; 2023 Jun; 42(3):109-114. PubMed ID: 37343169
[TBL] [Abstract][Full Text] [Related]
7. Immunization of mice with a newly identified thyroid-stimulating hormone receptor splice variant induces Graves'-like disease.
Endo T; Kobayashi T
J Autoimmun; 2013 Jun; 43():18-25. PubMed ID: 23538203
[TBL] [Abstract][Full Text] [Related]
8. Graves' Disease Mechanisms: The Role of Stimulating, Blocking, and Cleavage Region TSH Receptor Antibodies.
Morshed SA; Davies TF
Horm Metab Res; 2015 Sep; 47(10):727-34. PubMed ID: 26361259
[TBL] [Abstract][Full Text] [Related]
9. The thyrotropin receptor in Graves' disease.
Rapoport B; McLachlan SM
Thyroid; 2007 Oct; 17(10):911-22. PubMed ID: 17822379
[TBL] [Abstract][Full Text] [Related]
10. Evidence that TSH Receptor A-Subunit Multimers, Not Monomers, Drive Antibody Affinity Maturation in Graves' Disease.
Rapoport B; Aliesky HA; Chen CR; McLachlan SM
J Clin Endocrinol Metab; 2015 Jun; 100(6):E871-5. PubMed ID: 25856215
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and discrimination of autoimmune Graves' disease and Hashimoto's disease using thyroid-stimulating hormone receptor-containing recombinant proteoliposomes.
Fukushima H; Matsuo H; Imamura K; Morino K; Okumura K; Tsumoto K; Yoshimura T
J Biosci Bioeng; 2009 Dec; 108(6):551-6. PubMed ID: 19914592
[TBL] [Abstract][Full Text] [Related]
12. Thyroid-stimulating hormone receptor and its role in Graves' disease.
Chistiakov DA
Mol Genet Metab; 2003 Dec; 80(4):377-88. PubMed ID: 14654350
[TBL] [Abstract][Full Text] [Related]
13. Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy.
Bahn RS; Dutton CM; Natt N; Joba W; Spitzweg C; Heufelder AE
J Clin Endocrinol Metab; 1998 Mar; 83(3):998-1002. PubMed ID: 9506762
[TBL] [Abstract][Full Text] [Related]
14. The formation of thyrotropin receptor (TSHR) antibodies in a Graves' animal model requires the N-terminal segment of the TSHR extracellular domain.
Kikuoka S; Shimojo N; Yamaguchi KI; Watanabe Y; Hoshioka A; Hirai A; Saito Y; Tahara K; Kohn LD; Maruyama N; Kohno Y; Niimi H
Endocrinology; 1998 Apr; 139(4):1891-8. PubMed ID: 9528975
[TBL] [Abstract][Full Text] [Related]
15. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies to the thyrotropin receptor.
Ando T; Davies TF
Clin Dev Immunol; 2005 Jun; 12(2):137-43. PubMed ID: 16050145
[TBL] [Abstract][Full Text] [Related]
17. Targeting the thyrotropin receptor in thyroid disease.
El-Kaissi S; Wall JR
Expert Opin Ther Targets; 2012 Jul; 16(7):719-27. PubMed ID: 22621289
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of a monoclonal antibody to the thyrotropin receptor that acts as a powerful thyroid-stimulating autoantibody antagonist.
Sanders J; Allen F; Jeffreys J; Bolton J; Richards T; Depraetere H; Nakatake N; Evans M; Kiddie A; Premawardhana LD; Chirgadze DY; Miguel RN; Blundell TL; Furmaniak J; Smith BR
Thyroid; 2005 Jul; 15(7):672-82. PubMed ID: 16053383
[TBL] [Abstract][Full Text] [Related]
19. Graves' immunoglobulins activate phospholipase A2 by recognizing specific epitopes on thyrotropin receptor.
Di Cerbo A; Di Paola R; Menzaghi C; De Filippis V; Tahara K; Corda D; Kohn LD
J Clin Endocrinol Metab; 1999 Sep; 84(9):3283-92. PubMed ID: 10487700
[TBL] [Abstract][Full Text] [Related]
20. Thyrotropin receptor expression in orbital adipose/connective tissues from patients with thyroid-associated ophthalmopathy.
Bahn RS
Thyroid; 2002 Mar; 12(3):193-5. PubMed ID: 11952038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
